I. Solovic (Vysne Hagy, Slovakia), P. Magyar (Budapest, Hungary)
Structure of M. tuberculosis drug resistance in penitentiary institutions of Belarus
P. S. Kryvanos, G. S. Avdeev, A. F. Grinevich (Minsk, Belarus)
|  |
Secondary drug resistance tuberculosis in Iran
M. V. Amiri, M. Mirsaeidi, P. Tabaresi, D. Mansouri, M. Masjedi, K. Kiahashemi, A. Velayati (Tehran, Islamic Republic Of Iran)
| |
Artificial pneumothorax in the treatment of multi drug resistant tuberculosis (MDR TB)
I. Motus, S. Skorniakov, E. Egorov, E. Kildyusheva, A. Savel‘ev, G. Zaletaeva (Ekaterinburg, Russian Federation)
| |
The significance of smear result at two month in pulmonary tuberculosis
M. V. Cirstoniu, V. I. Muresan (Cluj Napoca, Romania)
| |
Study of inhaled antitubercular drugs in healthy human volunteers & cases of resistant pulmonary TB
S. K. Katiyar, S. Bihari (Kanpur, India)
| |
In vitro and vivo study of isoxyl, a mycolic acid inhibitor for intermittent chemotherapy of multi drug resistant (MDR) strains of mycobacterium tuberculosis (M.tb)
S. P. Vaidya, M. G. Kulkarni, G. V. Koppikar, S. Kari (Mumbai, India)
| |
Safety and efficacy of linezolid, clarithromycin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis
S. K. Agarwal, N. Singh (Varanasi, India)
| |
A prospective study of multiple drug-resistant tuberculosis in Plovdiv region, Bulgaria, 1989–2004
A. A. Torossian, I. I. Gaidarova, V. A. Hodgev, G. I. Belev, E. N. Bachiiska, I. I. Nikolov, P. V. Mandulova (Plovdiv, Bulgaria)
| |
Primary drug resistance against mycobacterium tuberculosis in a high burden country
M. Irfan, N. A. Rao, S. J. Hussain (Karachi, Pakistan)
| |
MDR TB in Macedonia in the last five years
A. A. Vidoevska, S. J. Talevski, C. D. Vragoterova (Skopje, Fyrom)
| |
Effects of DOTS strategy on new confirmed tuberculosis
D. S. Zivkovic, M. M. Zivkovic, M. M. Radovic, S. M. Golubovic, L. Ristic, M. H. Rancic, T. N. Pejcic, I. J. Stankovic (Nis, Serbia And Montenegro)
| |
Effectiveness and safety of gatifloxacin in patients with drug resistance tuberculosus befor unsuccessfully treated with ofloxacin and ciprofloxacin
S. A. Cherenko, E. R. Tarasenko (Kiev, Ukraine)
| |
Which is the level of education among TB and MDR TB patients about their disease? A patient‘s questionnaire
M. C. Ciontu, A. I. Dragomir, A. Dumitrescu (Bucharest, Romania)
| |
The most frequent mistakes in TB treatment
G. Barbulescu (Bucharest, Romania)
| |
Features of cytokine production, subpopulation structure of lymphocytes and functional state of neutrophils in patients with disseminated MDR tuberculosis
L. K. Surkova, N. S. Shpakovskaya, A. M. Zalutskaya, A. M. Skrahina (Minsk, Belarus)
| |
MDR-tuberculosis in a school community
M. I. Gheorghiu-Branaru, F. Branzoi, N. Galie, M. C. E. Gheorghiu-Branaru, C. Didilescu (Bucharest, Romania)
| |
Romanian county tuberculosis laboratory accreditation, 2005–2006
D. I. A. N. Chiotan, I. Husar, L. Ditiu, D. Homorodean, N. Poll, M. Samoila, I. P. Stoicescu (Bucharest, Cluj, Romania)
| |
Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment
U. K. Dasgupta, S. K. Sadhukhan (Kamarhati, Calcutta, India)
| |
Tuberculosis 1995–2004: evaluation of the resistance of mycobacterium tuberculosis to anti-TBC drugs in Greece
T. Topalis, E. Fakiri, V. Chandrinos, A. Charalampopoulou, P. Kalomitsinis, P. Kritis, E. Papafrangas, P. Ziotopoulos (Athens, Greece)
| |
Rapid detection of M. tuberculosis gene mutations associated with drug resistance by modified allele-specific real-time PCR
Y. S. Alyapkina, M. A. Vladimirsky, D. A. Varlamov, J. I. Alekseev, L. K. Shipina (Moscow, Russian Federation)
| |